Advertisement

Pediatric Nephrology

, Volume 25, Issue 5, pp 957–959 | Cite as

Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin

  • Hiroshi Kaito
  • Koichi Kamei
  • Eriko Kikuchi
  • Masao Ogura
  • Kentaro Matsuoka
  • Michio Nagata
  • Kazumoto Iijima
  • Shuichi Ito
Brief Report

Abstract

We report a case of a 2-year-old boy with steroid- and ciclosporin (CsA)-resistant collapsing focal segmental glomerulosclerosis (FSGS) who went into complete remission with a combination of IV rituximab and methylprednisolone pulse therapy (MPT) while receiving oral CsA. He was initially treated with steroids including MPT, CsA, and plasmapheresis, but his massive proteinuria and severe systemic edema persisted. We treated him with four weekly doses of intravenous rituximab. After the second administration of rituximab, his proteinuria and systemic edema were dramatically improved, but hypoalbuminemia and proteinuria persisted. Eight months after the onset, he was re-treated with two courses of MPT. Thereafter, he finally went into complete remission 1 month after MPT. He continued in remission for 8 months with CsA, but then relapsed. However, he went into complete remission again with 60 mg/m2 of oral prednisolone without rituximab and since then, he has been in remission with CsA. This is the first report of the successful treatment of collapsing FSGS with rituximab. Thus, rituximab emerges as a new therapeutic option against refractory collapsing FSGS.

Keywords

Focal segmental glomerulosclerosis Collapsing glomerulopathy Steroid-resistant nephrotic syndrome Rituximab Methylprednisolone pulse therapy Ciclosporin 

Notes

Acknowledgement

We acknowledge Dr. Satoshi Hisano, Assistant Professor of Pathology at Fukuoka University Faculty of Medicine, for his pathological advice and support.

References

  1. 1.
    Detwiler RK, Falk RJ, Hogan SL, Jennette JC (1994) Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416–1424CrossRefPubMedGoogle Scholar
  2. 2.
    Singh HK, Baldree LA, McKenney DW, Hogan SL, Jennette JC (2000) Idiopathic collapsing glomerulopathy in children. Pediatr Nephrol 14:132–137CrossRefPubMedGoogle Scholar
  3. 3.
    Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 356:2751–2752CrossRefPubMedGoogle Scholar
  4. 4.
    Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K (2008) Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol 23:481–485CrossRefPubMedGoogle Scholar
  5. 5.
    Laurinavicius A, Hurwitz S, Rennke HG (1999) Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int 56:2203–2213CrossRefPubMedGoogle Scholar
  6. 6.
    Suri M, Tran K, Sharma AP, Filler G, Grimmer J (2008) Remission of steroid-resistant nephrotic syndrome due to focal segmental glomerulosclerosis using rituximab. Int Urol Nephrol 40:807–810CrossRefPubMedGoogle Scholar
  7. 7.
    Kimmel PL, Mishkin GJ, Umana WO (1996) Captoril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 28:202–208CrossRefPubMedGoogle Scholar
  8. 8.
    Chun MJ, Korbet SM, Schwartz MM, Lewis EJ (2004) Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 15:2169–2177CrossRefPubMedGoogle Scholar
  9. 9.
    Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60:242–247PubMedGoogle Scholar
  10. 10.
    Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Camus CH, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine- dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269–1279CrossRefPubMedGoogle Scholar
  11. 11.
    Sharma AP, Filler G (2009) Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab. Pediatr Nephrol 24:423–424CrossRefPubMedGoogle Scholar

Copyright information

© IPNA 2009

Authors and Affiliations

  • Hiroshi Kaito
    • 1
    • 4
  • Koichi Kamei
    • 1
  • Eriko Kikuchi
    • 1
  • Masao Ogura
    • 1
  • Kentaro Matsuoka
    • 2
  • Michio Nagata
    • 3
  • Kazumoto Iijima
    • 4
  • Shuichi Ito
    • 1
  1. 1.Department of NephrologyNational Center for Child Health and DevelopmentSetagaya, TokyoJapan
  2. 2.Department of PathologyNational Center for Child Health and DevelopmentSetagaya, TokyoJapan
  3. 3.Department of PathologyUniversity of TsukubaTsukuba, IbaragiJapan
  4. 4.Department of PediatricsKobe University Graduate School of MedicineChuo-ku, KobeJapan

Personalised recommendations